Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), sold 13,622 shares at $15.69 ($214K) on 2022-10-25, disclosed to the SEC on 2022-10-26.
Open-market sale of $214k ANTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.17 | 2,866 | $46K | 21.6% |
| 2 | $15.69 | 4,272 | $67K | 31.3% |
| 3 | $15.69 | 4,272 | $67K | 31.3% |
| 4 | $16.20 | 534 | $9K | 4.0% |
| 5 | $15.10 | 1,678 | $25K | 11.8% |
| Total | $15.74 avg | 13,622 |
| $214K |
| 100% |
| Filing → |
| ANTX | SELL | 2024-01-04 | $112K | — | Filing → |
| ANTX | BUY | 2023-05-15 | $54K | — | Filing → |
| ANTX | SELL | 2022-11-14 | $136K | — | Filing → |